Skip to main content
All lobbying filings

BGR GOVERNMENT AFFAIRS

Lobbying for ASSOCIATION FOR RESPONSIBLE HEALTHCARE INVESTMENT · Healthcare investment company

 Amended
The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Apr 20, 2026.
 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Jan 12, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Florida

Official filing document

 Lobbyists on this filing 4
  • ERSKINE W WELLS
    Previously held: Dep COS Sen. Wicker; COS Rep. Palazzo; Leg Asst Sen Wicker; Intern Sen. Cochran
  • REMY LEIGH BRIM MASON
    Previously held: Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
  • ROBB WALTON
    Previously held: Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes
  • MARVIN BENITO FIGUEROA
    Previously held: COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White House

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 1
Health Issues

Provide strategic counsel and advocacy on federal policy proposals impacting private investment in healthcare. This includes legislative and regulatory initiatives related to clinical autonomy, workforce support, access to care in underserved communities, health system modernization, and transparency and accountability in healthcare delivery and investment.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem